2 Million+
Patients served
200,000+
5-star Reviews
12+
Years in operation
300+
Team members and growing
Book Online
Modern. Clean. Extended hours.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
174th Street, Bronx, NY
Confirm the specific service at the intended site before traveling. Ask which part of evaluation and follow-up takes place there, how to arrange it and whether your chosen treatment is available at that location.
Ask whether the site provides buprenorphine evaluation, a particular depot injection, naltrexone assessment or referral. Methadone for OUD generally uses an opioid treatment program. A general OUD location listing should lead to the appropriate service rather than assuming every option is administered there.
Bring treatment records, the last medicine or injection and urgent access concerns. Confirm where ongoing prescribing, injections and behavioral care occur and who manages a gap. If symptoms need another level of care, ask for the appropriate assessment pathway instead of waiting for a routine visit.
Treatment for opioid use disorder starts with an assessment of opioid use, withdrawal, overdose risk and what you want to change. Medicines can reduce withdrawal or cravings and help protect recovery. Treatment can be appropriate after heroin, fentanyl, nonprescribed pills or problematic prescription opioid use. An evaluation is still useful if you are uncertain about the diagnosis or have returned to use after earlier treatment.
Buprenorphine and methadone activate opioid receptors in controlled ways; naltrexone blocks them and requires an opioid-free starting point. They have different entry requirements and do not offer an identical experience. Naloxone reverses an opioid overdose but is not ongoing OUD treatment. Withdrawal management by itself does not resolve the longer-term risk of relapse and overdose.
The clinician reviews frequency and route of use, loss of control, consequences, tolerance and withdrawal, while distinguishing prescribed use and physical dependence from OUD. Pregnancy, severe symptoms, intoxication, other substance use and health conditions affect the safest setting. Bring any current OUD prescription: transferring care does not necessarily mean starting over, but records and an assessment are needed.
Describe the last opioid use, uncertain pill contents, prior overdoses and current symptoms. Include alcohol, sedatives, stimulants and pain treatment. The clinician assesses whether an outpatient plan is safe or whether urgent, hospital or another level of care is needed. An overdose or unstable condition should not wait for an ordinary clinic appointment.
Compare buprenorphine, methadone and naltrexone against your clinical needs and preferences. Buprenorphine initiation needs a safe plan after recent opioid exposure. Methadone for OUD generally requires an opioid treatment program. Naltrexone requires detoxification and opioid-free assessment. A clinic should help with a suitable referral when the chosen treatment is outside its verified services.
Clarify formulation, pharmacy or injection logistics, return visits, monitoring and whom to call for access problems. Address pain and mental-health treatment at the same time. Discuss counseling, recovery support and barriers such as transportation, housing or work hours without assuming one service can provide every resource.
Have naloxone and an overdose-response plan. Identify what to do after missed medication, renewed use or hospital discharge. A return to use needs reassessment of symptoms, dose coverage and other risks; it should not be hidden because you fear the visit will be wasted.
Bring identification if required for registration, a medication list, pharmacy details, recent treatment records and relevant insurance information. Tell the clinician if you are nearly out of medication or cannot obtain it. Ask how the first prescription or injection is arranged and what follow-up is required. Do not take borrowed treatment or create an opioid-free interval without advice to prepare for the visit.
Call 911 for possible overdose, slow breathing, unresponsiveness, severe chest pain or collapse. Use available naloxone for suspected opioid overdose and follow the product instructions. Alcohol and sedatives can sharply increase risk with opioids or OUD medicines. After a period without opioids, tolerance can be lower, making return to previous use especially dangerous. Pregnancy, dehydration or uncontrolled withdrawal can require urgent assessment.
Ongoing visits review withdrawal, craving patterns, substance use, function and medication effects. Testing, when clinically appropriate, should help interpret the treatment picture; it is not a complete diagnosis by itself. Discuss whether the plan needs more support, a different formulation or another treatment setting. Effective medication may continue for a long time. Stopping requires a plan for relapse prevention and overdose safety.
Ask what the service actually provides: evaluation, ongoing prescribing, injections, counseling or referral. Confirm the specific location, appointment availability, fees and pharmacy or payer requirements. Same-day availability depends on assessment, the intended service and supply. If the requested medicine is unavailable, ask for a safe interim or referral plan rather than waiting without a next step.
Nao Medical 174Th Street: 932 E 174th St, Bronx, NY 10460. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
For patients using a self-pay path for Suboxone-based care, current self-pay pricing is $350 for the initial visit including UDS, $200 for follow-up visits including UDS, and $100 for a short bridge visit when clinically appropriate.
Queens
37-15 23rd Ave, Astoria, NY 11105
A western Queens location for opioid addiction treatment, buprenorphine follow-up, and realistic neighborhood access.
View local MAT care Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx option for opioid use disorder care, bridge-review visits, and practical next-step coordination.
View local MAT care Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A central Brooklyn location for medication for addiction treatment, follow-up planning, and local access that is easier to keep using.
View local MAT care Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island location for opioid addiction treatment, medication follow-up, and insurance-supported recovery care.
View local MAT care Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A central Queens clinic for timely addiction medicine evaluation, Suboxone follow-up, and practical neighborhood access.
View local MAT care Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A southeast Queens location for opioid use disorder care, bridge review, and clear follow-up planning.
View local MAT care Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A workday-friendly Queens location for medication treatment, monitoring, and repeat follow-up visits.
View local MAT care Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A core Long Island location for opioid addiction treatment, insurance review, and reliable ongoing follow-up.
View local MAT care Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan location for addiction medicine visits, medication follow-up, and structured treatment planning.
View local MAT care Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn location for medication for addiction treatment, same-day access review, and practical ongoing care.
View local MAT care Get directionsLocal Suboxone care is the strongest next step for patients who already know the main treatment path they are trying to start or continue.
Local Sublocade care helps when the question is about a monthly injectable option rather than a broader MAT intake.
Local VIVITROL care helps when the question is about monthly injectable naltrexone for alcohol dependence or opioid relapse prevention after detoxification.
Choose same-day access if the timing question matters more than the location question right now.
Choose bridge-prescription review if the urgent issue is a short-gap refill or keeping treatment moving until the next full follow-up.
Arrange an evaluation to discuss suitable care, preparation and follow-up with a clinician.
Book addiction medicine visitNao Medical offers assessment and follow-up for opioid use disorder, including buprenorphine treatment when clinically appropriate. Choose an addiction-care appointment and bring your current medicines and treatment history. If a pharmacy cannot fill a prescription, contact the prescriber and pharmacy promptly to discuss an appropriate alternative or transfer. Do not change the dose or use someone else’s medicine while waiting.
Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.
Ask the selected service for the next available appointment for opioid-use-disorder assessment or medication follow-up. Confirm whether booking or a walk-in visit is appropriate before traveling. Bring current medicines, earlier treatment records and any required paperwork. Starting medication or completing a letter or testing depends on the clinician’s assessment and the records available.
A bridge-care evaluation addresses a possible gap in buprenorphine treatment while ongoing care is being arranged. It may be relevant after hospital discharge, a lost appointment, a move or a change in prescriber. The clinician reviews the current treatment and safety before deciding what interim care is appropriate. A bridge prescription is not automatic and should connect to a definite next step.
Bring the current product, prescription details, usual schedule, last dose and remaining supply. Explain why the gap occurred and identify the ongoing or previous prescriber. The clinician reviews recent opioid use, symptoms, sedatives, overdose history and other conditions. Severe withdrawal, intoxication or another unstable condition may need urgent care or a different setting.
Bring the bottle, pharmacy record, discharge summary or clinic instructions. Give the date of the next planned visit and whether it has been confirmed. If records cannot be obtained immediately, explain what is missing so the clinician can decide what additional verification is needed.
Tell the clinician about every dose missed and any fentanyl, heroin, methadone or other opioid used since the interruption. Do not treat restarting as a simple refill when exposure has changed. Review alcohol, benzodiazepines, new medicines and symptoms that might affect the plan.
If interim prescribing is appropriate, clarify the product, pharmacy, written instructions and follow-up endpoint. Ask which clinician will manage the next prescription and how information will be transferred with appropriate consent. A short-term solution should not leave the next gap unexplained.
Contact the team promptly if the pharmacy cannot dispense the medicine or an authorization is delayed. Give the actual reason provided rather than guessing. The clinician and pharmacy may need to clarify the prescription or choose another safe access step. Do not substitute borrowed medicine or assume the gap has been solved until dispensing is confirmed.
Confirm that the service reviews bridge requests, what records are needed and whether the requested appointment is available. A same-day appointment does not guarantee a controlled-medication prescription or pharmacy supply. Ask about evaluation and follow-up costs separately from medication. If the current service cannot safely take over, request a clear referral or continuity plan.
Fentanyl-related opioid use disorder can be treated, including when you have struggled with earlier attempts to start medication. An evaluation reviews the actual use pattern, previous withdrawal or precipitated withdrawal, overdose risk and treatment preferences. The safest start cannot be guaranteed by waiting a fixed number of hours or copying a forum schedule.
Tell the clinician whether fentanyl was expected, whether exposure involved powders or pills and whether stimulants or other substances were also used. Describe past overdoses, treatment attempts and the last opioid exposure. Pregnancy, severe symptoms, breathing problems and sedating medicines influence the safest setting. A previous difficult initiation is important information rather than proof that treatment is impossible.
Bring any prior OUD prescription and describe what happened when it was started. Include the timing of symptoms, other opioids and whether an emergency visit was needed. The clinician uses this information and current assessment to plan care; a clock alone is not enough.
Discuss buprenorphine, a methadone program referral when appropriate, or naltrexone after suitable detoxification. A clinician may use an individualized initiation approach and decide where monitoring is needed. Follow the individualized initiation instructions from your clinician.
Oral buprenorphine, Sublocade and weekly or monthly Brixadi have different starting requirements. A long-acting injection is not automatically the first step for every patient. Confirm the product, the supervised assessment and the follow-up plan before administration.
Clarify pharmacy or injection access and what happens if symptoms persist or an appointment is missed. Have naloxone and teach trusted people how to respond. Address pain, sleep, mental health and practical barriers so treatment remains usable after the initial visit.
Call 911 for slow breathing, inability to wake, collapse or possible overdose. Give available naloxone according to its product instructions; repeat doses may be needed and emergency assessment remains necessary. Severe withdrawal, dehydration, chest pain or confusion needs timely assessment. Opioid tolerance can fall during a treatment gap or period without use, increasing danger if use resumes.
